The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma.

This study was designed to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on paclitaxel (PTX) tumor distribution and antitumor activity in xenograft models of human ovarian carcinoma...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Cesca, M, Frapolli, R, Berndt, A, Scarlato, V, Richter, P, Kosmehl, H, D'Incalci, M, Ryan, A, Giavazzi, R
التنسيق:	Journal article
اللغة:	English
منشور في:	2009

مواد مشابهة

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma
حسب: Marta Cesca, وآخرون
منشور في: (2009-11-01)

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
حسب: Edmond Auzenne, وآخرون
منشور في: (2007-06-01)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
حسب: Wachsberger, P, وآخرون
منشور في: (2009)

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging.
حسب: Lavinia Morosi, وآخرون
منشور في: (2013-01-01)

Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
حسب: Choi, S, وآخرون
منشور في: (2008)

Modulation of gene expression associated with copy number variation identifies key regulatory programs in high-grade serous ovarian carcinoma
حسب: Martina Vescio, وآخرون
منشور في: (2023-07-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
حسب: Demuytere J, وآخرون
منشور في: (2024-01-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
حسب: Hideki Iwamoto, وآخرون
منشور في: (2011-03-01)

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
حسب: Cervellini, I, وآخرون
منشور في: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
حسب: Tai, J, وآخرون
منشور في: (2010)

Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat
حسب: Tai, J, وآخرون
منشور في: (2010)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
حسب: Nils Degrauwe, وآخرون
منشور في: (2012-06-01)

Selective use of vandetanib in the treatment of thyroid cancer
حسب: Fallahi P, وآخرون
منشور في: (2015-07-01)

Biophysical and computational characterization of vandetanib–lysozyme interaction
حسب: Kabir, Md Zahirul, وآخرون
منشور في: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
حسب: Abdul Qadir, MPhil, وآخرون
منشور في: (2023-10-01)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
حسب: Jade Cury-Martins, وآخرون
منشور في: (2018-10-01)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
حسب: Roberta Affatato, وآخرون
منشور في: (2022-05-01)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
حسب: Zhou, J, وآخرون
منشور في: (2016)

Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
حسب: Alferez, D, وآخرون
منشور في: (2010)

Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
حسب: Heymach, J, وآخرون
منشور في: (2008)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
حسب: Francesca Ricci, وآخرون
منشور في: (2017-05-01)

Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
حسب: Siemann, D, وآخرون
منشور في: (2009)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
حسب: Yuxin Shen, وآخرون
منشور في: (2025-03-01)

Effect of Vandetanib Treatment on Cystic Changes in the Liver following Metastasis from Medullary Thyroid Carcinoma
حسب: Ai Matsui, وآخرون
منشور في: (2022-01-01)

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis
حسب: Paola De Feudis, وآخرون
منشور في: (2000-05-01)

Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
حسب: Joseph J. Caumanns, وآخرون
منشور في: (2025-02-01)

N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma
حسب: T. Laragione, وآخرون
منشور في: (2005-01-01)

Nitric oxide synthase inhibition enhances the antitumor effect of radiation in the treatment of squamous carcinoma xenografts.
حسب: Robert J G Cardnell, وآخرون
منشور في: (2011-01-01)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
حسب: Fallahi P, وآخرون
منشور في: (2019-08-01)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
حسب: Busra Demirbag Gul, وآخرون
منشور في: (2022-02-01)

Antitumor action of an aminochromene derivative on human - derived lung adenocarcinoma xenograft model
حسب: E. A. Samishina, وآخرون
منشور في: (2019-06-01)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
حسب: Carlos M. Galmarini, وآخرون
منشور في: (2014-01-01)

Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
حسب: Alberto Zambelli, وآخرون
منشور في: (2023-01-01)

Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
حسب: Jr, W, وآخرون
منشور في: (2012)

Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
حسب: Pepe D, وآخرون
منشور في: (2016-05-01)

LAMININ-5. A POTENTIAL TOOL IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
حسب: Hartwig Kosmehl, وآخرون
منشور في: (2002-12-01)

Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib
حسب: Sravanthi Sanivarapu, MD, وآخرون
منشور في: (2018-09-01)

Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer
حسب: Meijia Yu, وآخرون
منشور في: (2024-05-01)

BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
حسب: Federica Guffanti, وآخرون
منشور في: (2024-06-01)

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
حسب: Kumar, K, وآخرون
منشور في: (2013)